Investigators at Moores Cancer Center at University of California, San Diego identified an increase in patients presenting with late-stage diagnoses for breast and colorectal cancers during the COVID-19 pandemic.
Jade Zhou, MD, PhD, a hematology and oncology fellow at Moores, and her co-investigators retrospectively reviewed staging data for patients who presented to the cancer center in 2019 and 2020.
The researchers documented staging at presentation using an American Joint